Since APP is a major substrate of the multi-protein γ-secretase complex and its cleavage contributes to the generation of amyloidogenic Aβ peptide species, inhibition of the γ-secretase has attracted much attention as a promising therapy for AD. The gene discussed is APP; the disease is Alzheimer disease.